thiamineWhat was measured
Measured, with no finding
2,290 endpoints
Show what was measuredHide what was measured
plasma thiamine + thiamine monophosphate, type 1 diabetic patients versus age-matched normal subjects
decreases, p = 0.05
The plasma content of thiamine + thiamine monophosphate in type 1 diabetic patients (35.3 +/- 3.6 pmol/mL) was significantly lower when compared with that measured in six age-matched normal subjects (53.2 +/- 2.3 pmol/mL, P < 0.05)
PMID 10436256 · one of two readings recorded this
erythrocyte transketolase activation coefficient (ETK-AC)
decreases
The activation coefficient (ETK-AC) decreased significantly from 1.10 to 1.04 vs. 1.12 to 1.07 in both the BTMP as well as TN groups, respectively
PMID 10507244 · one of two readings recorded this
erythrocyte transketolase activation coefficient (ETK-AC)
decreases
The activation coefficient (ETK-AC) decreased significantly from 1.10 to 1.04 vs. 1.12 to 1.07 in both the BTMP as well as TN groups, respectively
PMID 10507244 · one of two readings recorded this
TDP AUC0-24h in whole blood, BTMP versus TN
increases
The AUC0-24h of TDP in whole blood after BTMP ingestion exceeded those after TN ingestion by 420%
PMID 10507244 · one of two readings recorded this
TDP concentration in whole blood, fold increase from baseline to Cmax
increases
The TDP concentration in whole blood increased by 2.6 and 1.4 times from baseline levels to Cmax in the BTMP and TN groups, respectively
PMID 10507244 · one of two readings recorded this
TDP concentration in whole blood, fold increase from baseline to Cmax
increases
The TDP concentration in whole blood increased by 2.6 and 1.4 times from baseline levels to Cmax in the BTMP and TN groups, respectively
PMID 10507244 · one of two readings recorded this
urinary excretion of administered dose
Only 1.0 vs. 0.6% of the administered dose were excreted in urine in the BTMP group and TN group, respectively
PMID 10507244 · one of two readings recorded this
urinary excretion of administered dose
Only 1.0 vs. 0.6% of the administered dose were excreted in urine in the BTMP group and TN group, respectively
PMID 10507244 · one of two readings recorded this
fibroblast pyruvate dehydrogenase activity at normal thiamine pyrophosphate concentration
decreases
pyruvate dehydrogenase activity was studied again with thiamine pyrophosphate concentration adjusted to the normal human tissue level and found to be deficient
PMID 10872106 · one of two readings recorded this
fibroblast pyruvate dehydrogenase activity with routine assay
no effect
Fibroblast pyruvate dehydrogenase assayed with routine method was normal
PMID 10872106 · one of two readings recorded this
neurological status after thiamine treatment
increases
because of neurological improvement after treatment with thiamine, pyruvate dehydrogenase activity was studied again
PMID 10872106 · one of two readings recorded this
alpha-ETK (transketolase activation coefficient)
decreases, p = 0.04
Likewise, alpha-ETK decreased from initially 1.10+/-0.07 to 1.04+/-0.04 (P = 0.04) and from 1.12+/-0.05 to 1.08+/-0.06 (P = 0.09)
PMID 10952481 · one of two readings recorded this
alpha-ETK (transketolase activation coefficient)
no effect, p = 0.09
Likewise, alpha-ETK decreased from initially 1.10+/-0.07 to 1.04+/-0.04 (P = 0.04) and from 1.12+/-0.05 to 1.08+/-0.06 (P = 0.09)
PMID 10952481 · one of two readings recorded this
erythrocyte thiamine diphosphate concentration and erythrocyte transketolase activity after single oral benfotiamine 100 mg versus thiamine nitrate 100 mg in ESRD patients
ratio of maximum erythrocyte TDP to basal 2.66+/-0.6 (benfotiamine) versus 1.44+/-0.2 (thiamine nitrate)
Not recorded as a finding: the comparison was against another active treatment
The ratio between the maximum erythrocyte TDP concentration and basal concentration was 2.66+/-0.6 in the benfotiamine group and 1.44+/-0.2 in the group receiving thiamine nitrate (P < 0.001).
PMID 10952481 · one of two readings recorded this
erythrocyte transketolase activity
increases, p = 0.02
The transketolase activity increased from 3.54+/-0.7 microkat/l initially to 3.84+/-0.6 microkat/l after benfotiamine intake (P = 0.02) and from 3.71+/-0.8 microkat/l to 4.02+/-0.7 microkat/l after thiamine nitrate intake (P = 0.08)
PMID 10952481 · one of two readings recorded this
erythrocyte transketolase activity
no effect, p = 0.08
The transketolase activity increased from 3.54+/-0.7 microkat/l initially to 3.84+/-0.6 microkat/l after benfotiamine intake (P = 0.02) and from 3.71+/-0.8 microkat/l to 4.02+/-0.7 microkat/l after thiamine nitrate intake (P = 0.08)
PMID 10952481 · one of two readings recorded this
peak plasma TDP concentration in ESRD patients versus healthy subjects
increases
After benfotiamine administration, the peak plasma concentration of TDP exceeded that in healthy subjects by 51%
PMID 10952481 · one of two readings recorded this
phosphorylation ratio in whole blood
decreases, p = 0.02
After 24 h, the phosphorylation ratio in whole blood decreased from 12.9+/-6.9 initially to 5.6+/-3.2 after benfotiamine administration (P = 0.02) and from 13.5+/-7.3 to 9.0+/-4.8 (P = 0.03) after administration of thiamine nitrate
PMID 10952481 · one of two readings recorded this
phosphorylation ratio in whole blood
decreases, p = 0.03
After 24 h, the phosphorylation ratio in whole blood decreased from 12.9+/-6.9 initially to 5.6+/-3.2 after benfotiamine administration (P = 0.02) and from 13.5+/-7.3 to 9.0+/-4.8 (P = 0.03) after administration of thiamine nitrate
PMID 10952481 · one of two readings recorded this
ratio of erythrocyte TDP concentration to basal concentration
increases
After 24 h, it was 2.11+/-0.4 and 1.23+/-0.2, respectively
PMID 10952481 · one of two readings recorded this
ratio of erythrocyte TDP concentration to basal concentration
increases
After 24 h, it was 2.11+/-0.4 and 1.23+/-0.2, respectively
PMID 10952481 · one of two readings recorded this
ratio of maximum to basal erythrocyte TDP concentration
increases, p = 0.001
The ratio between the maximum erythrocyte TDP concentration and basal concentration was 2.66+/-0.6 in the benfotiamine group and 1.44+/-0.2 in the group receiving thiamine nitrate (P < 0.001)
PMID 10952481 · one of two readings recorded this
ratio of maximum to basal erythrocyte TDP concentration
increases, p = 0.001
The ratio between the maximum erythrocyte TDP concentration and basal concentration was 2.66+/-0.6 in the benfotiamine group and 1.44+/-0.2 in the group receiving thiamine nitrate (P < 0.001)
PMID 10952481 · one of two readings recorded this
TDP blood AUC, benfotiamine versus thiamine nitrate
increases
the patients with ESRD had a 4.3 times higher area under the concentration time curve after benfotiamine administration than after thiamine nitrate
PMID 10952481 · one of two readings recorded this
TDP concentration in erythrocytes
increases
In the ESRD patients, after 24 h, the mean TDP concentration in erythrocytes increased from 158.7+/-30.9 ng/ml initially to 325.8+/-50.9 ng/ml after administration of benfotiamine and from 166.2+/-51.9 ng/ml to 200.5+/-50.0 ng/ml after thiamine nitrate administration
PMID 10952481 · one of two readings recorded this
TDP concentration in erythrocytes
increases
In the ESRD patients, after 24 h, the mean TDP concentration in erythrocytes increased from 158.7+/-30.9 ng/ml initially to 325.8+/-50.9 ng/ml after administration of benfotiamine and from 166.2+/-51.9 ng/ml to 200.5+/-50.0 ng/ml after thiamine nitrate administration
PMID 10952481 · one of two readings recorded this
mean plasma thiamine level
n = 70
Seventy patients participated and had a mean plasma thiamine level of 27.3 microg/dL (95% CI = 20.2 to 34.4)
PMID 11015250 · one of two readings recorded this
mean plasma thiamine level
than patients receiving dietary support (n = 44, 31.5 microg/dL, 95% CI = 24.7 to 38.3, 7% thiamine-deficient)
PMID 11015250 · one of two readings recorded this
mean plasma thiamine level
decreases
Patients not receiving dietary supplements or tube feedings (n = 26) had lower mean thiamine levels (20.3 microg/dL, 95% CI = 12.7 to 27.9) and were thiamine-deficient more often (27%)
PMID 11015250 · one of two readings recorded this
prevalence of thiamine deficiency (<10 microg/dL)
Fourteen percent (n = 10, 95% CI = 8% to 24%) were thiamine-deficient (<10 microg/dL)
PMID 11015250 · one of two readings recorded this
prevalence of thiamine deficiency (<10 microg/dL)
than patients receiving dietary support (n = 44, 31.5 microg/dL, 95% CI = 24.7 to 38.3, 7% thiamine-deficient)
PMID 11015250 · one of two readings recorded this
prevalence of thiamine deficiency (<10 microg/dL)
increases
Patients not receiving dietary supplements or tube feedings (n = 26) had lower mean thiamine levels (20.3 microg/dL, 95% CI = 12.7 to 27.9) and were thiamine-deficient more often (27%)
PMID 11015250 · one of two readings recorded this
high thiamine pyrophosphate effect (TPPE >15%), indicating thiamine deficiency
increases, p = 0.057, n = 28
High (>15%) thiamine pyrophosphate effect (TPPE), indicating thiamine deficiency, was found in five out of 14 CLL patients (35.7%) and in none of the controls (p=0.057)
PMID 11524517 · one of two readings recorded this
increment of more than 20% in total leucocyte count over the preceding three months
increases
which was found in all five thiamine deficient patients compared with only one of the nine non-thiamine deficient CLL patients
PMID 11524517 · one of two readings recorded this
mean TPPE in thiamine deficient CLL patients
Mean (SD) TPPE in the thiamine deficient patients group was 21.6 (3.4)%
PMID 11524517 · one of two readings recorded this
thiamine status by thiamine pyrophosphate effect (TPPE) in untreated B-CLL patients versus controls
increases, p = 0.057, n = 28
Not recorded as a finding: the compound is what was measured, not what was given
High (>15%) thiamine pyrophosphate effect (TPPE), indicating thiamine deficiency, was found in five out of 14 CLL patients (35.7%) and in none of the controls (p=0.057).
PMID 11524517 · one of two readings recorded this
association of ETKA with maternal symptoms or thiamine supplement use
no effect
No significant associations between ETKA and putative maternal symptoms or use of thiamine supplements were found
PMID 11722964 · one of two readings recorded this
severe thiamine deficiency by erythrocyte transketolase activity (ETKA > 1.25%)
thiamine deficiency reflected by an erythrocyte transketolase activity (ETKA) > or = 1.20% was found in 57.7% (15/26) of mothers, 26.9% (7/26) of whom had severe deficiency (ETKA > 1.25%)
PMID 11722964 · one of two readings recorded this
thiamine deficiency by erythrocyte transketolase activity (ETKA >= 1.20%)
thiamine deficiency reflected by an erythrocyte transketolase activity (ETKA) > or = 1.20% was found in 57.7% (15/26) of mothers, 26.9% (7/26) of whom had severe deficiency (ETKA > 1.25%)
PMID 11722964 · one of two readings recorded this
thiamine status by erythrocyte transketolase activity (ETKA) at 3 months postpartum in Karen refugee women
no effect, no significant association between ETKA and use of thiamine supplements
Not recorded as a finding: the compound is what was measured, not what was given
No significant associations between ETKA and putative maternal symptoms or use of thiamine supplements were found.
PMID 11722964 · one of two readings recorded this
maximum blood concentration (Cmax) of thiamine and AUC of thiamine and thiamine pyrophosphate after 150 mg i.v. over 1 h versus 24 h
increases, Cmax 2300 ng/mL after rapid infusion versus 177 ng/mL after slower infusion
Not recorded as a finding: the comparison was against another active treatment
The maximum blood concentrations (Cmax) of thiamine were significantly higher after the more rapid infusion (RI; 2300 ng/mL) than after the slower infusion (SI; 177 ng/mL).
PMID 12605618 · one of two readings recorded this
thiamine Cmax, AUC, thiamine pyrophosphate AUC and urinary excretion of thiamine after 150 mg i.v. over 1 h versus 24 h
no effect, AUC of thiamine identical after both infusion protocols
Not recorded as a finding: the comparison was against another active treatment
The AUC of thiamine was identical after both infusion protocols.
PMID 12605618 · one of two readings recorded this
thiamine Cmax in blood
decreases, n = 12
The maximum blood concentrations (Cmax) of thiamine were significantly higher after the more rapid infusion (RI; 2300 ng/mL) than after the slower infusion (SI; 177 ng/mL)
PMID 12605618 · one of two readings recorded this
TPP AUC, slower versus rapid infusion
increases, p = 0.08, n = 12
There was a slightly (10%) increased AUC of TPP (P < 0.08) after SI
PMID 12605618 · one of two readings recorded this
urinary excretion of thiamine, percent of applied dose
decreases, n = 12
Urinary excretion of thiamine was significantly decreased from 83.6% of the applied dose after RI to 57.6% after the SI
PMID 12605618 · one of two readings recorded this
erythrocyte thiamine diphosphate (TDP)
decreases
TDP=127.4+/-62.5 nmol/l (P<10(-5))
PMID 12742126 · one of two readings recorded this
erythrocyte thiamine diphosphate (TDP)
Mean control values obtained were: T=89.6+/-22.7 nmol/l, TMP=4.4+/-6.6 nmol/l and TDP=222.23+/-56.3 nmol/l
PMID 12742126 · one of two readings recorded this
erythrocyte thiamine monophosphate (TMP)
Mean control values obtained were: T=89.6+/-22.7 nmol/l, TMP=4.4+/-6.6 nmol/l and TDP=222.23+/-56.3 nmol/l
PMID 12742126 · one of two readings recorded this
erythrocyte thiamine (T)
decreases, p = 0.001
T and TDP mean values of alcoholics were significantly lower than those of control cases: T=69.4+/-35.9 nmol/l (P<0.001)
PMID 12742126 · one of two readings recorded this
erythrocyte thiamine (T)
Mean control values obtained were: T=89.6+/-22.7 nmol/l, TMP=4.4+/-6.6 nmol/l and TDP=222.23+/-56.3 nmol/l
PMID 12742126 · one of two readings recorded this
24-h copper balance during CRRT
decreases
The 24-h balances were negative for selenium (-0.97 micromol, or 2 times the daily RI), copper (-6.54 micromol, or 0.3 times the daily RI), and thiamine (-4.12 mg, or 1.5 times the RI) and modestly positive for zinc (20.7 micromol, or 0.2 times the RI)
PMID 15277163 · one of two readings recorded this
24-h selenium balance during CRRT
decreases
The 24-h balances were negative for selenium (-0.97 micromol, or 2 times the daily RI), copper (-6.54 micromol, or 0.3 times the daily RI), and thiamine (-4.12 mg, or 1.5 times the RI) and modestly positive for zinc (20.7 micromol, or 0.2 times the RI)
PMID 15277163 · one of two readings recorded this
24-h thiamine balance during CRRT
decreases
The 24-h balances were negative for selenium (-0.97 micromol, or 2 times the daily RI), copper (-6.54 micromol, or 0.3 times the daily RI), and thiamine (-4.12 mg, or 1.5 times the RI) and modestly positive for zinc (20.7 micromol, or 0.2 times the RI)
PMID 15277163 · one of two readings recorded this
24-h zinc balance during CRRT
increases
The 24-h balances were negative for selenium (-0.97 micromol, or 2 times the daily RI), copper (-6.54 micromol, or 0.3 times the daily RI), and thiamine (-4.12 mg, or 1.5 times the RI) and modestly positive for zinc (20.7 micromol, or 0.2 times the RI)
PMID 15277163 · one of two readings recorded this
thiamine 24-h balance (fluids administered minus effluent losses) during continuous venovenous hemodiafiltration, compared with recommended parenteral intake
-4.12 mg, or 1.5 times the RI
Not recorded as a finding: the compound is what was measured, not what was given
The 24-h balances were negative for selenium (-0.97 micromol, or 2 times the daily RI), copper (-6.54 micromol, or 0.3 times the daily RI), and thiamine (-4.12 mg, or 1.5 times the RI) and modestly positive for zinc (20.7 micromol, or 0.2 times the RI).
PMID 15277163 · one of two readings recorded this
correlation of vitamin B1 level with cerebellar size
increases, p = 0.028
vitamin B1 level correlated with cerebellar size in alcoholics even if the vitamin B1 concentration was within normal values (r = 0.344, p = 0.028)
PMID 15778906 · one of two readings recorded this
dentate nuclei MRI signal intensity
no effect, p = 0.15
dentate nuclei intensity was not significantly decreased in patients with chronic alcohol consumption (mean +/- SD signal intensity 65.36 +/- 13.0) if compared with control subjects (mean +/- SD signal intensity 68.95 +/- 9.4) (p = 0.15)
PMID 15778906 · one of two readings recorded this
anaemia and diabetes mellitus response to thiamine
unclear
The anaemia and diabetes mellitus responded to oral thiamine hydrochloride 25 mg/d, but during puberty thiamine supplements became ineffective
PMID 16373304 · one of two readings recorded this
anaemia and diabetes mellitus response to thiamine
no effect
The anaemia and diabetes mellitus responded to oral thiamine hydrochloride 25 mg/d, but during puberty thiamine supplements became ineffective
PMID 16373304 · one of two readings recorded this
T158R missense mutation in control alleles
no effect, n = 100
We have identified a novel missense mutation (T158R) that was excluded in 100 control alleles
PMID 16373304 · one of two readings recorded this
oxidative stress, inflammatory and nutritional markers (albumin, hsCRP, IL-6, AOPP, pentosidine, 8-OHdG)
no effect, n = 40
In both groups, over 8 weeks of follow-up, no significant differences could be observed in oxidative stress, inflammatory, or nutritional markers
PMID 16567267 · one of two readings recorded this
serum albumin, plasma hsCRP, IL-6, advanced oxidation protein products, pentosidine and 8-hydroxy-2'-deoxyguanosine in hemodialysis patients over 8 weeks
no effect, no significant differences in oxidative stress, inflammatory or nutritional markers
Not recorded as a finding: the intervention held more than the compound
In both groups, over 8 weeks of follow-up, no significant differences could be observed in oxidative stress, inflammatory, or nutritional markers.
PMID 16567267 · one of two readings recorded this
serum albumin, plasma hsCRP, IL-6, advanced oxidation protein products, pentosidine and 8-hydroxy-2'-deoxyguanosine in hemodialysis patients
no effect, no evidence that high doses of thiamine and pyridoxine affect oxidative stress, n = 40
Not recorded as a finding: the intervention held more than the compound
There was no evidence showing that high doses of thiamine and pyridoxine affects oxidative stress in hemodialysis patients.
PMID 16567267 · one of two readings recorded this
mean preoperative thiamine level
Male patients presented with greater mean preoperative thiamine levels (3.2 microg /dL) than female patients (2.4 microg/dL)
PMID 16925281 · one of two readings recorded this
mean preoperative thiamine level
Male patients presented with greater mean preoperative thiamine levels (3.2 microg /dL) than female patients (2.4 microg/dL)
PMID 16925281 · one of two readings recorded this
prevalence of low preoperative thiamine levels
Forty-seven patients (15.5%) presented with low preoperative thiamine levels.
PMID 16925281 · one of two readings recorded this
lower limb neuropathy after spinal anesthesia
n = 1
We present the case of a 65-year-old man with latent thiamine deficiency who manifested lower limb neuropathy after receiving spinal anesthesia
PMID 17175435 · one of two readings recorded this
Neuropathy Symptom Score and Total Symptom Score after 6 weeks of benfotiamine 300 or 600 mg/day versus placebo
no effect, TSS showed no significant differences after 6 weeks
Not recorded as a finding: the paper never mentions the compound
The TSS (Total Symptom Score) showed no significant differences after 6 weeks of treatment.
PMID 18473286 · one of two readings recorded this
Neuropathy Symptom Score (NSS), intention-to-treat population
unclear, p = 0.055, n = 133
In the ITT (intention to treat) population, the improvement of NSS was slightly above significance (p=0.055)
PMID 18473286 · one of two readings recorded this
Neuropathy Symptom Score (NSS), per-protocol population
decreases, p = 0.033, n = 124
After 6 weeks of treatment, the primary outcome parameter NSS (Neuropathy Symptom Score) differed significantly between the treatment groups (p=0.033) in the PP (per protocol) population
PMID 18473286 · one of two readings recorded this
Neuropathy Symptom Score (NSS, primary) and Total Symptom Score (TSS) after 6 weeks of benfotiamine 300 or 600 mg/day versus placebo in diabetic polyneuropathy
no effect, TSS showed no significant differences after 6 weeks
Not recorded as a finding: the paper never mentions the compound
The TSS (Total Symptom Score) showed no significant differences after 6 weeks of treatment.
PMID 18473286 · one of two readings recorded this
blood thiamine levels (nmol/L) and proportion below 150 nmol/L under a cereal-rich versus a vegetable-rich hypocaloric diet
increases, blood thiamine levels increased only with diet C at 2 and 6 weeks, n = 57
Not recorded as a finding: this platform holds no node for the endpoint
Thiamine intake and blood thiamine levels only increased with diet C (both at 2 and 6 weeks).
PMID 18608543 · one of two readings recorded this
blood thiamine levels (proportion below 150 nmol/L) in overweight/obese women on a cereal-based versus a vegetable-based hypocaloric diet
increases, blood thiamine levels increased only with the cereal diet at 2 and 6 weeks
Not recorded as a finding: this platform holds no node for the endpoint
Thiamine intake and blood thiamine levels only increased with diet C (both at 2 and 6 weeks).
PMID 18608543 · one of two readings recorded this
proportion of women with blood thiamine below 150 nmol/L
decreases
at 6 weeks of intervention only 3.7% of the women in diet C, as compared with 30.8% of the women in diet V, showed blood thiamine levels <150 nmol/L
PMID 18608543 · one of two readings recorded this
proportion of women with blood thiamine below 150 nmol/L
unclear
at 6 weeks of intervention only 3.7% of the women in diet C, as compared with 30.8% of the women in diet V, showed blood thiamine levels <150 nmol/L
PMID 18608543 · one of two readings recorded this
anion gap
group 1 (21.4%) with a normal anion gap (5.5 +/- 5.2 mmol/l) and group 2 (78.6%) with a wide anion gap (21.2 +/- 5.2 mmol/l)
PMID 18613556 · one of two readings recorded this
anion gap
group 1 (21.4%) with a normal anion gap (5.5 +/- 5.2 mmol/l) and group 2 (78.6%) with a wide anion gap (21.2 +/- 5.2 mmol/l)
PMID 18613556 · one of two readings recorded this
high lactate level
33.3% had a high lactate level (2.2 mmol/l); none had thiamine deficiency (TPPE < 20%)
PMID 18613556 · one of two readings recorded this
high lactate level
High lactate (3.5 +/- 1.4 mmol/l) was found in 54.5% of group 2 and thiamine deficiency was observed in 18.2% of this group
PMID 18613556 · one of two readings recorded this
normal lactate level
Sixty-six point seven percent of patients in group 1 had a normal lactate level (1.5 +/- 0.8 mmol/l)
PMID 18613556 · one of two readings recorded this
thiamine deficiency by TPPE
no effect
33.3% had a high lactate level (2.2 mmol/l); none had thiamine deficiency (TPPE < 20%)
PMID 18613556 · one of two readings recorded this
thiamine deficiency by TPPE
High lactate (3.5 +/- 1.4 mmol/l) was found in 54.5% of group 2 and thiamine deficiency was observed in 18.2% of this group
PMID 18613556 · one of two readings recorded this
Days of glucose infusion before Wernicke's encephalopathy
decreases
The five subjects with albumin plasma levels lower than 35 g/L at the onset of WE received glucose infusion for fewer days
PMID 18929463 · one of two readings recorded this
Persistent mental dysfunction with Korsakoff's syndrome despite prolonged thiamine treatment
In one case mental function did not normalize and the patient developed Korsakoff's syndrome despite prolonged thiamine treatment
PMID 18929463 · one of two readings recorded this
Resolution of clinical signs the day after thiamine infusion
decreases
In six cases the clinical signs disappeared the day after thiamine infusion
PMID 18929463 · one of two readings recorded this
Time from start of glucose infusion to onset of Wernicke's encephalopathy
WE occurred, on average, 13 d after the start of glucose infusion
PMID 18929463 · one of two readings recorded this
change in urinary albumin excretion (UAE) from baseline
no effect, n = 20
There was no significant decrease in UAE in patients receiving placebo after 3 months of therapy (n = 20)
PMID 19057893 · one of two readings recorded this
change in urinary albumin excretion (UAE) from baseline
decreases, p = 0.001, n = 20
UAE was decreased in patients receiving thiamine therapy for 3 months with respect to baseline (median -17.7 mg/24 h; p < 0.001, n = 20)
PMID 19057893 · one of two readings recorded this
urinary albumin excretion (UAE) at 3 months, thiamine versus placebo
decreases, p = 0.01
UAE was significantly lower in patients who had received thiamine therapy compared with those who had received placebo (30.1 vs 35.5 mg/24 h, p < 0.01)
PMID 19057893 · one of two readings recorded this
urinary albumin excretion (UAE), mg/24 h, assay not stated, thiamine 3 x 100 mg/day versus placebo for 3 months
decreases, UAE 30.1 vs 35.5 mg/24 h, thiamine vs placebo, n = 40
Not recorded as a finding: the paper never states the instrument the node requires
UAE was significantly lower in patients who had received thiamine therapy compared with those who had received placebo (30.1 vs 35.5 mg/24 h, p < 0.01) but not at baseline.
PMID 19057893 · one of two readings recorded this
urinary albumin excretion (UAE), mg/24 h, thiamine 3 x 100 mg/day versus placebo for 3 months
decreases, UAE 30.1 vs 35.5 mg/24 h, thiamine versus placebo
Not recorded as a finding: the paper never states the instrument the node requires
UAE was significantly lower in patients who had received thiamine therapy compared with those who had received placebo (30.1 vs 35.5 mg/24 h, p < 0.01) but not at baseline.
PMID 19057893 · one of two readings recorded this
folate above upper limit of reference range among patients with low thiamine diphosphate
n = 39
28 (72%) of the 39 had folate levels higher than the upper limit of the reference range
PMID 19083422 · one of two readings recorded this
folate above upper limit of reference range among patients with normal thiamine
p = 0.01, n = 41
In 41 patients with normal thiamine levels, only 14 (34%) had folate levels higher than the upper limit of the reference range (chi(2) test, P < .01)
PMID 19083422 · one of two readings recorded this
repeated thiamine diphosphate level after oral antibiotic therapy
increases, n = 9
Nine of these patients then received oral antibiotic therapy; repeated thiamine levels were found to be normal in all 9 patients
PMID 19083422 · one of two readings recorded this
repeated thiamine diphosphate level after oral thiamine supplements
no effect, n = 15
Fifteen patients received oral thiamine supplements, but repeated thiamine levels remained low in all 15
PMID 19083422 · one of two readings recorded this
thiamine diphosphate below lower limit of reference range
n = 80
In these 80 patients, 39 (49%) had thiamine diphosphate levels less than the lower limit of the reference range
PMID 19083422 · one of two readings recorded this
heart rate after exercise
decreases, n = 27
after exercise, heart rate was lower after taking TPP than after placebo
PMID 19094430 · one of two readings recorded this
heart rate at rest
no effect, n = 27
At rest, heart rate after taking placebo or TPP was similar
PMID 19094430 · one of two readings recorded this
maximum oxygen consumption (Vo(2max)) during exercise
increases, n = 27
During exercise, Vo(2max) in athletes on TPP was higher than on placebo
PMID 19094430 · one of two readings recorded this
serum lactate after exercise
decreases, n = 27
after exercise, the levels were lower in the athletes after taking TPP than after placebo
PMID 19094430 · one of two readings recorded this
serum lactate at rest
no effect, n = 27
At rest, serum lactate levels after placebo or TPP were similar
PMID 19094430 · one of two readings recorded this
serum lactate, maximum oxygen consumption (VO2max) and heart rate in male athletes after TPP 1 mg/kg versus placebo, crossover
increases, VO2max higher on TPP than on placebo
Not recorded as a finding: the paper never mentions the compound
During exercise, Vo(2max) in athletes on TPP was higher than on placebo.
PMID 19094430 · one of two readings recorded this
serum lactate, Vo(2max) and heart rate at rest and after exercise, thiamine pyrophosphate 1 mg/kg versus placebo
increases, Vo(2max) higher on TPP than on placebo, n = 27
Not recorded as a finding: the paper never mentions the compound
During exercise, Vo(2max) in athletes on TPP was higher than on placebo.
PMID 19094430 · one of two readings recorded this
age at independent walking
unclear, p = 0.001
The study and control groups differed significantly in the expressive communication (p<0.001) and auditory comprehension language subscales (p<0.001), the Mental Developmental Index score (p<0.001), and age at independent walking (p=0.001)
PMID 19191836 · one of two readings recorded this
auditory comprehension language subscale
unclear, p = 0.001
The study and control groups differed significantly in the expressive communication (p<0.001) and auditory comprehension language subscales (p<0.001), the Mental Developmental Index score (p<0.001), and age at independent walking (p=0.001)
PMID 19191836 · one of two readings recorded this
correlation of receptive language score with age at independent walking
unclear, p = 0.005
A significant correlation was found between the receptive language score and age at independent walking, i.e. poorer language associated with later walking (r=-0.601, p=0.005)
PMID 19191836 · one of two readings recorded this
expressive communication language subscale
unclear, p = 0.001
The study and control groups differed significantly in the expressive communication (p<0.001) and auditory comprehension language subscales (p<0.001), the Mental Developmental Index score (p<0.001), and age at independent walking (p=0.001)
PMID 19191836 · one of two readings recorded this
Mental Developmental Index score
unclear, p = 0.001
The study and control groups differed significantly in the expressive communication (p<0.001) and auditory comprehension language subscales (p<0.001), the Mental Developmental Index score (p<0.001), and age at independent walking (p=0.001)
PMID 19191836 · one of two readings recorded this
preoperative thiamine blood concentration
no effect
Preoperative thiamine blood concentrations were within the normal range in both groups
PMID 19342609 · one of two readings recorded this
thiamine blood concentration below normal range
decreases, n = 7
Among the 7 patients receiving peripheral parenteral nutrition without thiamine, the thiamine concentration in 3 patients was below the normal range on the fifth postoperative day
PMID 19342609 · one of two readings recorded this
thiamine blood concentration over postoperative days 1 to 5 in children on peripheral parenteral nutrition with or without thiamine
Not recorded as a finding: this platform holds no node for the endpoint
In the group receiving peripheral parenteral nutrition without thiamine, the thiamine concentration gradually decreased with time after the operation, whereas the concentration remained within the normal range in the group receiving peripheral parenteral nutrition with thiamine.
PMID 19342609 · one of two readings recorded this
thiamine blood concentration over time after operation
no effect
whereas the concentration remained within the normal range in the group receiving peripheral parenteral nutrition with thiamine
PMID 19342609 · one of two readings recorded this
thiamine blood concentration over time after operation
decreases
In the group receiving peripheral parenteral nutrition without thiamine, the thiamine concentration gradually decreased with time after the operation
PMID 19342609 · one of two readings recorded this
Anemia
decreases
We report a 4-year-old girl with TRMA whose anemia improved following administration of thiamine
PMID 19347672 · one of two readings recorded this
absence of missense variants in healthy controls
n = 50
the absence of the missense variants in healthy normals was confirmed in 50 unrelated individuals (i.e. 100 chromosomes)
PMID 19643445 · one of two readings recorded this
hearing in compound heterozygote Patient 2
Notably, in one case (Patient 2), a compound heterozygote, the hearing is normal even at 15 years of age
PMID 19643445 · one of two readings recorded this
novel SLC19A2 mutations identified
By determining the sequence of SLC19A2 in all probands we identified nine novel mutations amongst these seven families
PMID 19643445 · one of two readings recorded this
sensory-neural hearing deficit in compound heterozygote Patient 5
Another compound heterozygote (Patient 5) has only minimal sensory-neural hearing deficit at 30 years of age
PMID 19643445 · one of two readings recorded this
Reversion of clinical features including cardiologic abnormalities to normalcy
Low levels of erythrocyte transketolase activity suggested thiamine deficiency that was confirmed by reversion of several clinical features including cardiologic abnormalities to normalcy on thiamine supplementation
PMID 19934228 · one of two readings recorded this
Abnormal prenatal brain development with severe non-progressive encephalopathy
n = 12
Abnormal prenatal brain development resulted in severe non-progressive encephalopathy with callosal agenesis, gyration anomalies, microcephaly with intrauterine growth retardation, or dysmorphia in both males and females (12 cases)
PMID 20002125 · one of two readings recorded this
Acute energy failure in infant life producing basal ganglia lesions, paroxysmal dystonia, neuropathic ataxia or epilepsy
n = 11
Acute energy failure in infant life produced basal ganglia lesions with paroxysmal dystonia, neuropathic ataxia due to axonal transport dysfunction, or epilepsy only in males (11 cases)
PMID 20002125 · one of two readings recorded this
Mutations involving PDHA1
n = 17
Seventeen mutations involved PDHA1 (a hotspot was identified in exons 6, 7, and 8 in seven males with Leigh syndrome or recurrent ataxia)
PMID 20002125 · one of two readings recorded this
Paroxysmal dysfunction
decreases
The ketogenic diet improved only paroxysmal dysfunction, providing an additional argument in favour of paroxysmal energy failure
PMID 20002125 · one of two readings recorded this
PDHX mutations correlated with non-progressive encephalopathy and long-term survival
n = 5
Mutations in the PDHX gene (five cases) were correlated with non-progressive encephalopathy and long-term survival in four cases
PMID 20002125 · one of two readings recorded this
plasma thiamine, change from pre-CABG to 24 hours
decreases, p = 0.003
pre- to 24 hour thiamine levels were also statistically significantly lower (mean of differences= 8.5 nmol/Liters; [95% CI 3.6-13.3], p = 0.003)
PMID 20005469 · one of two readings recorded this
plasma thiamine, change from pre-CABG to 6 hours
no effect, p = 0.052
however pre- to 6 hour levels were not significantly lower (mean of differences = 5.8 nmol/Liters [−.06 – 11.7], p = 0.052)
PMID 20005469 · one of two readings recorded this
plasma thiamine, change from pre-CABG to immediately post-CABG
decreases, p = 0.0004
there was a statistically significant decrease in thiamine levels between the baseline (pre-CABG) and post-CABG serum thiamine levels (mean of differences = 10.14 nmol/Liters; [95% CI 5.6 – 14.7], p = 0.0004)
PMID 20005469 · one of two readings recorded this
plasma thiamine level (HPLC thiochrome) before and after coronary artery bypass graft surgery; surgery is the exposure, thiamine is measured
decreases, mean of differences 10.14 nmol/L, 95% CI 5.6-14.7, p = 0.0004
Not recorded as a finding: the compound is what was measured, not what was given
For the primary endpoint, there was a statistically significant decrease in thiamine levels between the baseline (pre-CABG) and post-CABG serum thiamine levels (mean of differences = 10.14 nmol/Liters; [95% CI 5.6 – 14.7], p = 0.0004).
PMID 20005469 · one of two readings recorded this
HDL cholesterol
no effect, p = 0.25
HDL cholesterol (mmol/l) | 1.2 ± 0.3 | 1.1 ± 0.3 | 1.2 ± 0.3 | 1.1 ± 0.3 | 1.1 ± 0.3 | 1.1 ± 0.3 | 0.25
PMID 20413516 · one of two readings recorded this
LDL cholesterol
no effect, p = 0.55
LDL cholesterol (mmol/l) | 1.9 ± 0.7 | 1.9 ± 0.8 | 2.1 ± 0.8 | 1.8 ± 0.9 | 1.8 ± 0.9 | 1.9 ± 0.9 | 0.55
PMID 20413516 · one of two readings recorded this
Triglycerides
no effect, p = 0.06
Triglycerides (mmol/l) | 1.8 (1.4–2.6) | 1.9 (1.4–2.8) | 1.7 (1.2–2.6) | 2.1 (1.4–3.4) | 2.2 (1.4–2.9) | 2.0 (1.2–2.9) | 0.06
PMID 20413516 · one of two readings recorded this
24-h UACR
no effect, p = 0.37
24-h UACR (mg/mmol) | 10.3 (3.7–23.4) | 6.1 (3.0–17.7) | 4.9 (2.5–18.4) | 7.6 (4.3–13.3) | 7.4 (2.8–11.0) | 7.1 (4.0–12.5) | 0.37
PMID 20413516 · one of two readings recorded this
24-h UAE change from baseline to 12 weeks
no effect
Change in UAE between baseline and 12 weeks was −18 mg/24 h in the benfotiamine group and −1 mg/24 h in the placebo group
PMID 20413516 · one of two readings recorded this
24-h urinary albumin excretion, immunonephelometry (primary outcome)
no effect, Benfotiamine treatment had no significant effect on primary or secondary outcome parameters.
Not recorded as a finding: The only prose sentence is a generic statement over all primary and secondary outcomes and does not name UAE; node urinary-albumin-excretion-rate requires a timed collection expressed as micrograms per minute, the paper reports mg/24 h.
Benfotiamine treatment had no significant effect on primary or secondary outcome parameters.
PMID 20413516 · one of two readings recorded this
24-h urinary albumin excretion (UAE, immunonephelometry) and urinary KIM-1 (ELISA) after 12 weeks of benfotiamine vs placebo in type 2 diabetes with nephropathy
no effect
Not recorded as a finding: the paper never mentions the compound
Benfotiamine treatment had no significant effect on primary or secondary outcome parameters.
PMID 20413516 · one of two readings recorded this
24-h urinary albumin excretion (UAE)
no effect, p = 0.36
UAE (mg/24 h) | 90 (38–267) | 75 (49–280) | 72 (38–199) | 97 (48–177) | 99 (43–200) | 96 (45–200) | 0.36
PMID 20413516 · one of two readings recorded this
24-h urinary KIM-1
no effect, p = 0.12
U-KIM-1 (μg/24 h) | 1.67 (0.95–2.47) | 1.51 (0.86–2.59) | 1.68 (1.06–2.40) | 1.56 (1.06–1.83) | 1.56 (1.06–1.83) | 1.39 (1.02–2.01) | 0.12
PMID 20413516 · one of two readings recorded this
Creatinine clearance
no effect, p = 0.57
Creatinine clearance (ml/min) | 135 ± 51 | 129 ± 53 | 133 ± 45 | 130 ± 58 | 139 ± 58 | 131 ± 64 | 0.57
PMID 20413516 · one of two readings recorded this
Cystatin C
no effect, p = 0.53
Cystatin C (mg/l) | 1.01 ± 0.21 | 1.06 ± 0.22 | 1.09 ± 0.23 | 1.03 ± 0.23 | 1.10 ± 0.26 | 1.11 ± 0.23 | 0.53
PMID 20413516 · one of two readings recorded this
Diastolic blood pressure
no effect, p = 0.68
DBP (mmHg) | 76 ± 8 | 77 ± 10 | 76 ± 9 | 76 ± 10 | 76 ± 9 | 76 ± 10 | 0.68
PMID 20413516 · one of two readings recorded this
Erythrocyte transketolase activity
increases, p = 0.001
TK activity (mU/mgHb) | 0.41 ± 0.10 | 0.51 ± 0.12 | 0.53 ± 0.15 | 0.38 ± 0.11 | 0.39 ± 0.08 | 0.41 ± 0.10 | <0.001
PMID 20413516 · one of two readings recorded this
HbA1c
no effect, p = 0.33
A1C (%) | 7.3 ± 0.9 | 7.1 ± 0.9 | 7.3 ± 1.0 | 7.4 ± 0.9 | 7.2 ± 0.9 | 7.2 ± 0.9 | 0.33
PMID 20413516 · one of two readings recorded this
Plasma creatinine
increases, p = 0.04
Plasma creatinine (μmol/l) | 84 ± 19 | 89 ± 19 | 88 ± 20 | 87 ± 23 | 89 ± 25 | 87 ± 21 | 0.04
PMID 20413516 · one of two readings recorded this
Spot-urine UACR
no effect, p = 0.58
Spot-urine UACR (mg/mmol) | 9.3 (2.4–16.8) | 5.8 (3.7–17.9) | 7.1 (3.6–17.8) | 6.2 (3.4–10.5) | 8.2 (3.9–14.2) | 8.1 (4.6–15.9) | 0.58
PMID 20413516 · one of two readings recorded this
Systolic blood pressure
no effect, p = 0.6
SBP (mmHg) | 140 ± 16 | 139 ± 14 | 143 ± 17 | 137 ± 20 | 140 ± 20 | 140 ± 17 | 0.60
PMID 20413516 · one of two readings recorded this
Urinary alpha1-microglobulin (24 h)
no effect, p = 0.33
U-α1m (mg/24 h) | 9.4 (4.3–24.4) | 11.9 (4.4–20.2) | 11.2 (4.1–18.8) | 8.2 (4.3–20.3) | 9.0 (5.7–21.1) | 10.2 (2.5–19.7) | 0.33
PMID 20413516 · one of two readings recorded this
Urinary alpha1-microglobulin/creatinine
no effect, p = 0.47
U-α1m/creatinine (mg/mmol) | 0.6 (0.3–1.4) | 0.7 (0.3–1.3) | 0.6 (0.3–1.2) | 0.6 (0.3–1.3) | 0.6 (0.3–1.4) | 0.7 (0.2–1.1) | 0.47
PMID 20413516 · one of two readings recorded this
Urinary KIM-1/creatinine
no effect, p = 0.37
U-KIM-1/creatinine (ng/mmol) | 103 (63–158) | 95 (66–170) | 96 (77–148) | 99 (79–141) | 89 (58–130) | 81 (66–150) | 0.37
PMID 20413516 · one of two readings recorded this
Urinary NGAL (24 h)
no effect, p = 0.17
U-Ngal (mg/24 h) | 131 (67–227) | 118 (77–229) | 115 (73–284) | 122 (53–224) | 112 (52–218) | 99 (52–222) | 0.17
PMID 20413516 · one of two readings recorded this
Urinary NGAL/creatinine
no effect, p = 0.18
U-Ngal/creatinine (mg/mmol) | 6.7 (4.3–13.9) | 6.2 (3.4–15.9) | 5.1 (3.2–12.9) | 7.7 (4.2–18.9) | 6.4 (3.2–15.1) | 8.5 (3.3–13.1) | 0.18
PMID 20413516 · one of two readings recorded this
whole-blood thiamine and erythrocyte transketolase activity (thiamine status), HPLC
increases, parameters of thiamine status improved significantly
Not recorded as a finding: No outcome node for whole-blood thiamine or transketolase activity.
In patients receiving benfotiamine, parameters of thiamine status improved significantly.
PMID 20413516 · one of two readings recorded this
Whole blood thiamine
increases, p = 0.001
Whole blood thiamine (nmol/l) | 126 ± 23 | 290 ± 31 | 300 ± 0 | 122 ± 23 | 124 ± 25 | 138 ± 30 | <0.001
PMID 20413516 · one of two readings recorded this
Absolute thiamine deficiency prevalence
n = 30
None of the 30 controls (0/30, 0%) exhibited absolute TD
PMID 20646908 · one of two readings recorded this
Absolute thiamine deficiency prevalence
n = 30
In the study group, 3 (10%) of 30 had absolute TD upon presentation
PMID 20646908 · one of two readings recorded this
Absolute thiamine deficiency prevalence
n = 26
Of the vasopressor-dependent population, 7.7% (2/26) displayed TD on presentation
PMID 20646908 · one of two readings recorded this
Additional absolute thiamine deficiency developing
n = 30
an additional 3 patients (6/30, 20%) developed TD within 72 hours
PMID 20646908 · one of two readings recorded this
Association of plasma thiamine with lactic acidosis after multivariable regression
decreases, p = 0.02
The relationship between thiamine and lactic acidosis held after multivariable regression analysis controlling for age, sex, and comorbid disease (P < .02)
PMID 20646908 · one of two readings recorded this
Correlation between plasma thiamine and lactic acidosis
no effect
For the group overall, there was no correlation between thiamine and lactic acidosis
PMID 20646908 · one of two readings recorded this
Correlation between plasma thiamine and lactic acidosis
decreases, p = 0.02
thiamine was statistically significantly negatively correlated with lactic acidosis (r = -.50; P = .02)
PMID 20646908 · one of two readings recorded this
fasting glucose, A1C, lipids, hs-CRP, IL-6, TNF-alpha, leptin and adiponectin before and after 1 month of thiamine 150 mg/day versus placebo
decreases, glucose 6.7 ± 1.0 vs 6.0 ± 1.0 mmol/l before and after thiamine, p = 0.024
Not recorded as a finding: the result compares a group with itself, not with a control
There were significant decreases in glucose (6.7 ± 1.0 mmol/l vs. 6.0 ± 1.0 mmol/l, p = 0.024) before and after the intervention, respectively, and leptin concentrations (32.9 ± 13.3 ng/ml vs. 26.9 ± 12.8 ng/ml, p = 0.027) before and after the intervention, respectively, with thiamine administration.
PMID 20652275 · one of two readings recorded this
fasting glucose and leptin before and after 1 month of thiamine 150 mg versus placebo in drug-naive type 2 diabetes
decreases, glucose 6.7 to 6.0 mmol/l; leptin 32.9 to 26.9 ng/ml, before vs after on thiamine, p = 0.024, n = 12
Not recorded as a finding: the result compares a group with itself, not with a control
There were significant decreases in glucose (6.7 ± 1.0 mmol/l vs. 6.0 ± 1.0 mmol/l, p = 0.024) before and after the intervention, respectively, and leptin concentrations (32.9 ± 13.3 ng/ml vs. 26.9 ± 12.8 ng/ml, p = 0.027) before and after the intervention, respectively, with thiamine administration.
PMID 20652275 · one of two readings recorded this
fasting glucose
decreases, p = 0.024
There were significant decreases in glucose (6.7 ± 1.0 mmol/l vs. 6.0 ± 1.0 mmol/l, p = 0.024) before and after the intervention
PMID 20652275 · one of two readings recorded this
leptin
decreases, p = 0.027
leptin concentrations (32.9 ± 13.3 ng/ml vs. 26.9 ± 12.8 ng/ml, p = 0.027) before and after the intervention, respectively, with thiamine administration
PMID 20652275 · one of two readings recorded this
memory performance in relation to whole blood thiamine level
Thiamine levels were selectively related to memory performance in the alcoholics
PMID 20962766 · one of two readings recorded this
proportion of alcoholics at risk for WE (one criterion)
Of the alcoholics examined, 27% met no criteria, 57% were at risk for WE, and 16% had signs of WE
PMID 20962766 · one of two readings recorded this
proportion of alcoholics meeting no Caine criteria for WE
Of the alcoholics examined, 27% met no criteria, 57% were at risk for WE, and 16% had signs of WE
PMID 20962766 · one of two readings recorded this
proportion of alcoholics with signs of WE (two or more criteria)
Of the alcoholics examined, 27% met no criteria, 57% were at risk for WE, and 16% had signs of WE
PMID 20962766 · one of two readings recorded this
Association of low blood thiamine with C-reactive protein >20 mg/dL
increases, p = 0.02, n = 202
independently associated with C-reactive protein concentrations >20 mg/dL (odds ratio: 2.17; 95% CI: 1.13, 4.17; P = 0.02)
PMID 21068344 · one of two readings recorded this
Association of low blood thiamine with malnutrition
no effect, n = 202
but not with malnutrition
PMID 21068344 · one of two readings recorded this
Association of low blood thiamine with mortality, length of stay and mechanical ventilation time
no effect, n = 202
No significant association was shown between low blood thiamine concentrations upon admission and outcome variables
PMID 21068344 · one of two readings recorded this
Prevalence of low blood thiamine upon admission
n = 202
Low blood thiamine concentrations upon admission were detected in 57 patients (28.2%)
PMID 21068344 · one of two readings recorded this
whole-blood thiamine concentration by HPLC on PICU admission as risk-factor outcome and predictor of mortality, length of stay and ventilation time
no effect
Not recorded as a finding: the compound is what was measured, not what was given
No significant association was shown between low blood thiamine concentrations upon admission and outcome variables.
PMID 21068344 · one of two readings recorded this
left ventricular ejection fraction (LVEF) treatment effect, absolute
increases, n = 9
This corresponds to a treatment effect for LVEF of 3.9% in absolute terms
PMID 22057652 · one of two readings recorded this
left ventricular ejection fraction (LVEF)
no effect, p = 0.911, n = 9
Baseline LVEF was similar for both treatment groups (29.5% in the thiamine group and 29.5% in the placebo group, P = 0.911)
PMID 22057652 · one of two readings recorded this
left ventricular ejection fraction (LVEF)
increases, p = 0.024, n = 9
After 28 days of thiamine treatment, the LVEF increased to 32.8% which was significantly (P = 0.024) different from the LVEF in the placebo group (28.8%)
PMID 22057652 · one of two readings recorded this
Blood thiamine
decreases
Blood thiamine, mammillary bodies and fornix volume, and fornix fiber bundle fractional anisotropy were significantly decreased as compared to controls
PMID 22172599 · one of two readings recorded this
Correlation of blood thiamine with mammillary bodies' volume
increases
Blood thiamine showed significant positive correlation with mammillary bodies' volume only
PMID 22172599 · one of two readings recorded this
Reversibility of blood thiamine and mammillary bodies' volume
increases, n = 7
In 7 acute liver failure patients, follow-up study was done after clinical recovery at 5 weeks
PMID 22172599 · one of two readings recorded this
AGE-DNA (DNA glycation) in DNA isolated from leukocytes, in diabetic nephropathy patients given vitamins B1 + B6 versus B6 alone
decreases, significant decrease in AGE-DNA values with combined B1 and B6
Not recorded as a finding: this platform holds no node for the endpoint
The combined administration of B(1) and B(6) caused a significant decrease in AGE-DNA values (p<0.05).
PMID 22231921 · one of two readings recorded this
AGE-DNA (glycation of leukocyte nuclear DNA) after vitamins B1 + B6 versus B6 alone in diabetic nephropathy
decreases, significant decrease in AGE-DNA with B1 + B6, n = 6
Not recorded as a finding: this platform holds no node for the endpoint
The combined administration of B(1) and B(6) caused a significant decrease in AGE-DNA values (p<0.05).
PMID 22231921 · one of two readings recorded this
AGE-DNA in leukocytes
increases, p = 0.05
AGE-DNA levels were found significantly higher in diabetic patients (p<0.05) than the healthy controls
PMID 22231921 · one of two readings recorded this
AGE-DNA in leukocytes
decreases, p = 0.05, n = 6
The combined administration of B(1) and B(6) caused a significant decrease in AGE-DNA values (p<0.05)
PMID 22231921 · one of two readings recorded this
AGE-DNA in leukocytes
no effect, n = 11
Importantly the administration of vitamin B(6) alone did not have such an effect
PMID 22231921 · one of two readings recorded this
correlation of AGE-DNA with PLP
decreases, p = 0.05, n = 30
AGE-DNA and PLP levels were negatively correlated in control patients (r= - 0.361, p<0.05)
PMID 22231921 · one of two readings recorded this
effect of dose on AUC0-10 hr, plasma
increases, p = 0.001
The overall effect of dose was significant (Plasma: ANOVA p < 0.001; Whole Blood: ANOVA p < 0.001)
PMID 22305197 · one of two readings recorded this
effect of dose on AUC0-10 hr, whole blood
increases, p = 0.001
The overall effect of dose was significant (Plasma: ANOVA p < 0.001; Whole Blood: ANOVA p < 0.001)
PMID 22305197 · one of two readings recorded this
pairwise comparison of mean AUC0-10 hr between doses
increases, p = 0.05
the mean AUC0-10 hr for each dose was also significantly different from the others (Student-Newman-Keuls procedure, p < 0.05)
PMID 22305197 · one of two readings recorded this
plasma and whole-blood total thiamine AUC0-10 hr, Cmax, Tmax and half-life after oral thiamine hydrochloride 100, 500 and 1500 mg, HPLC thiochrome
overall effect of dose significant for plasma and whole blood
Not recorded as a finding: this platform holds no node for the endpoint
The overall effect of dose was significant (Plasma: ANOVA p < 0.001; Whole Blood: ANOVA p < 0.001).
PMID 22305197 · one of two readings recorded this
slope of AUC0-10 hr vs dose
unclear, p = 0.4
whole blood | 2.14 | 0.40
PMID 22305197 · one of two readings recorded this
slope of AUC0-10 hr vs dose
unclear, p = 0.01
whole blood | 1.02 | < 0.01 | 0.14 | < 0.01
PMID 22305197 · one of two readings recorded this
slope of AUC0-10 hr vs dose
unclear, p = 0.06
whole blood | 1.42 | 0.06 | 0.29 | 0.03
PMID 22305197 · one of two readings recorded this
slope of Cmax vs dose
unclear, p = 0.01
whole blood | 1.02 | < 0.01 | 0.14 | < 0.01
PMID 22305197 · one of two readings recorded this
slope of Cmax vs dose
unclear, p = 0.03
whole blood | 1.42 | 0.06 | 0.29 | 0.03
PMID 22305197 · one of two readings recorded this
incident open-angle glaucoma cases over follow-up
n = 91
During a mean follow-up of 9.7 years (range 5.3–13.9 years), 91 (2.6%) developed OAG
PMID 22461101 · one of two readings recorded this
incident open-angle glaucoma defined by glaucomatous visual field loss at follow-up, Cox hazard ratio by tertile of dietary vitamin B1 intake from food frequency questionnaire
decreases
Not recorded as a finding: this platform holds no node for the endpoint
High intakes of retinol equivalents and vitamin B1 were associated with a decreased risk of OAG, whereas a high intake of magnesium was associated with an increased risk.
PMID 22461101 · one of two readings recorded this
incident open-angle glaucoma
p = 0.063
2nd | 1.62 (0.97–2.71; 0.063) | 0.99 (0.52–1.86; 0.966)
PMID 22461101 · one of two readings recorded this
incident open-angle glaucoma
p = 0.966
2nd | 1.62 (0.97–2.71; 0.063) | 0.99 (0.52–1.86; 0.966)
PMID 22461101 · one of two readings recorded this
incident open-angle glaucoma
p = 0.795
3rd | 1.08 (0.59–2.00; 0.795) | 0.97 (0.47–2.00; 0.930)
PMID 22461101 · one of two readings recorded this
incident open-angle glaucoma
p = 0.93
3rd | 1.08 (0.59–2.00; 0.795) | 0.97 (0.47–2.00; 0.930)
PMID 22461101 · one of two readings recorded this
incident open-angle glaucoma
p = 0.076
2nd | 0.54 (0.27–1.07; 0.076) | 0.53 (0.21–1.35; 0.185)
PMID 22461101 · one of two readings recorded this